USP39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.291400E-01
Normal-vs-Stage2
8.885800E-01
Normal-vs-Stage3
4.449200E-01
Normal-vs-Stage4
3.851800E-01
Stage1-vs-Stage2
3.333600E-01
Stage1-vs-Stage3
5.962200E-01
Stage1-vs-Stage4
1.304960E-01
Stage2-vs-Stage3
1.445840E-01
Stage2-vs-Stage4
4.867200E-01
Stage3-vs-Stage4
1.743010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.424000E-01
Normal-vs-AfricanAmerican
7.910200E-01
Normal-vs-Asian
9.553200E-01
Caucasian-vs-AfricanAmerican
6.345400E-01
Caucasian-vs-Asian
8.173400E-01
AfricanAmerican-vs-Asian
7.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.560000E-01
Normal-vs-Female
9.229600E-01
Male-vs-Female
2.777600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.432200E-01
Normal-vs-Age(41-60Yrs)
6.090200E-01
Normal-vs-Age(61-80Yrs)
8.724400E-01
Normal-vs-Age(81-100Yrs)
7.496000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.954200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.168000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.610000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.325600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.430000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.433800E-01
Normal-vs-Daily Drinker
8.177200E-01
Normal-vs-Weekly Drinker
8.363400E-01
Normal-vs-Occasional Drinker
4.544800E-01
Normal-vs-Social Drinker
6.910000E-01
Non Drinker-vs-Daily Drinker
7.243200E-01
Non Drinker-vs-Weekly Drinker
8.316800E-01
Non Drinker-vs-Occasional Drinker
1.201620E-01
Non Drinker-vs-Social Drinker
4.873200E-01
Daily Drinker-vs-Weekly Drinker
9.155800E-01
Daily Drinker-vs-Occasional Drinker
8.110000E-02
Daily Drinker-vs-Social Drinker
3.248000E-01
Weekly Drinker-vs-Occasional Drinker
1.064990E-01
Weekly Drinker-vs-Social Drinker
3.466000E-01
Occasional Drinker-vs-Social Drinker
3.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.226800E-01
Normal-vs-Grade 2
3.738300E-03
Normal-vs-Grade 3
2.384100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.462090E-03
Grade 1-vs-Grade 3
7.604000E-04
Grade 1-vs-Grade 4
1.226800E-01
Grade 2-vs-Grade 3
3.887600E-01
Grade 2-vs-Grade 4
3.738300E-03
Grade 3-vs-Grade 4
2.384100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.860400E-01
Normal-vs-NonDiabetic
9.940600E-01
Diabetic-vs-NonDiabetic
9.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.631600E-01
Normal-vs-NoPancreatitis
9.420200E-01
Pancreatitis-vs-NoPancreatitis
2.512300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.998400E-01
Normal-vs-N1
9.200400E-01
N0-vs-N1
9.979800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.415200E-01
Normal-vs-TP53-NonMutant
9.974400E-01
TP53-Mutant-vs-TP53-NonMutant
3.834100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
